Top 300 Pharm Drug Cards 22/23

Intended for the education of healthcare professionals

The quickest, most efficient way for mastering critical facts about common drugs

Perfect for NAPLEX and course review, McGraw Hill's 2022-2023 Top 300 Pharmacy Drug Cards is the most concise and up-to-date resource for building a solid knowledge base of the most commonly used drugs.

Each card includes:

• Generic and common name

• Dosage Forms

• Approved Dose and Indications

• Off-Label Use

• Contraindications

• Adverse Reactions

• Drug Interactions

• Monitoring Parameters

• Medication Safety Issues and Black Box Warnings

• Strong focus on patient safety

Adverse reactions are organized by common, less common, and rare but serious to help you organize your thoughts for counseling patients

No internet connection needed to view the full app. It is all ready for super quick image and information retrieval. This app is optimized for whatever size device you are using, either phone or tablet.

Each card also features a photograph as well as important drug information. You can also search the entire text with our lightning fast search tool. The search tool shows you suggested words as you type so it is quick and helps with spelling issues. You can also add notes to each drug card, as well as bookmark drug cards as Know and Don't Know to help with studying. You also have the ability to change the text size for easier reading.

This interactive app is based on the full content of McGraw-Hill’s 2022/2023 Top 300 Pharmacy Drug Cards.

ISBN-13: 978-1260467345

ISBN-10: 1260467341

Editors:

Jill M. Kolesar, PharmD, MS, BCPS, FCCP

University Research Professor, Colleges of Pharmacy and Medicine

Director, Precision Medicine Initiatives

Markey Cancer Center

University of Kentucky

Lexington, Kentucky

Lee C. Vermeulen, BSPharm, MS, FCCP, FFIP

Chief Efficiency Officer

UK HealthCare

Professor of Medicine and Pharmacy

University of Kentucky

Lexington, Kentucky

Disclaimer: This app is intended for the education of healthcare professionals and not as a diagnostic and treatment reference for the general population.

Developed by Usatine Media, LLC

Richard P. Usatine, MD, Co-President, Professor of Family & Community Medicine, Professor of Dermatology and Cutaneous Surgery, University of Texas Health Science Center San Antonio

Peter Erickson, Co-President, Lead Software Developer